Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Der Internist
|
July 8, 2015
[Personalized tumor therapy for gastrointestinal tumors]
T J Ettrich, L Perkhofer, T Seufferlein
Innere Medizin (Heidelberg, Germany)
|
May 24, 2023
[Metastatic colorectal cancer-Modern treatment strategies and sequences]
T J Ettrich, J S Schuhbaur, T Seufferlein
Zentralblatt Fur Chirurgie
|
July 13, 2013
[Colon Polypectomy - And Then?]
A W Berger, T J Ettrich, M M Dollinger
Der Internist
|
December 17, 2010
[Septic shock in a renal transplanted patient after consumption of uncooked pork meat]
T J Ettrich, C Lübbert, H Ebelt, et al.
Zeitschrift Fur Gastroenterologie
|
March 21, 2012
[Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin - first experiences from the EU-CORE registry study (European Cubicin® Outcomes Registry and Experience)]
C Lübbert, D Wilhelms, D Worlitzsch, et al.
BMC Medical Research Methodology
|
February 15, 2018
Advantages of a multi-state approach in surgical research: how intermediate events and risk factor profile affect the prognosis of a patient with locally advanced rectal cancer
G Manzini, T J Ettrich, M Kremer, et al.
BMC Cancer
|
October 25, 2019
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
L Perkhofer, A W Berger, A K Beutel, et al.
ESMO Open
|
February 12, 2022
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
L Weiss, M Karthaus, J Riera-Knorrenschild, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial
R Stelmach, S Lorenzen, T J Ettrich, et al.
Scientific Reports
|
September 15, 2019
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
T J Ettrich, D Schwerdel, A Dolnik, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Der Internist
|
July 8, 2015
[Personalized tumor therapy for gastrointestinal tumors]
T J Ettrich, L Perkhofer, T Seufferlein
Innere Medizin (Heidelberg, Germany)
|
May 24, 2023
[Metastatic colorectal cancer-Modern treatment strategies and sequences]
T J Ettrich, J S Schuhbaur, T Seufferlein
Zentralblatt Fur Chirurgie
|
July 13, 2013
[Colon Polypectomy - And Then?]
A W Berger, T J Ettrich, M M Dollinger
Der Internist
|
December 17, 2010
[Septic shock in a renal transplanted patient after consumption of uncooked pork meat]
T J Ettrich, C Lübbert, H Ebelt, et al.
Zeitschrift Fur Gastroenterologie
|
March 21, 2012
[Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin - first experiences from the EU-CORE registry study (European Cubicin® Outcomes Registry and Experience)]
C Lübbert, D Wilhelms, D Worlitzsch, et al.
BMC Medical Research Methodology
|
February 15, 2018
Advantages of a multi-state approach in surgical research: how intermediate events and risk factor profile affect the prognosis of a patient with locally advanced rectal cancer
G Manzini, T J Ettrich, M Kremer, et al.
BMC Cancer
|
October 25, 2019
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
L Perkhofer, A W Berger, A K Beutel, et al.
ESMO Open
|
February 12, 2022
Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial
L Weiss, M Karthaus, J Riera-Knorrenschild, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial
R Stelmach, S Lorenzen, T J Ettrich, et al.
Scientific Reports
|
September 15, 2019
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
T J Ettrich, D Schwerdel, A Dolnik, et al.
Page
of 2